Stock Valuation / NEOG

Is Neogen Corporation (NEOG) Overvalued? Fair Value & 5-Year Target

Neogen Corporation trades at $11.73 (P/E -45.12). Our reference model estimates a fair value of $-14.99 at its recent average P/E of 57.67.

What drives NEOG's valuation

Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric

Frequently asked questions

What is NEOG's fair value?

At its recent average P/E of 57.67, Neogen Corporation (NEOG) has a reference fair value of about $-14.99, which is -227.8% versus the current price of $11.73.

Is Neogen Corporation (NEOG) overvalued or undervalued?

Based on the average-P/E reference model, Neogen Corporation looks overvalued relative to fair value by roughly +227.8%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.

Open the interactive NEOG valuation dashboard →

Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.